Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Managing Diabetic Complications with Alternative Therapeutic Strategies

Author(s): Shobhit Prakash Srivastava, Pawan Upadhyay, Shibu Das, Neha Tiwari, Sudhanshu Mishra and Shivendra Mani Tripathi*

Volume 20, Issue 5, 2024

Published on: 21 September, 2023

Article ID: e070923220791 Pages: 10

DOI: 10.2174/1573399820666230907112430

Price: $65

Abstract

Diabetes is a chronic metabolic disease affecting millions worldwide. It is characterized by a lack of insulin production or impaired insulin function, leading to elevated blood glucose levels. Conventional treatment methods for diabetes management typically include lifestyle changes and medications. However, alternative therapies have gained attention in recent years, including traditional medicine containing bioactive compounds, supplements like vitamin D and Omega-3 fatty acids, aromatherapy, and homeopathy. Diabetic complications are common in patients with uncontrolled diabetes and can lead to serious health problems, including diabetic retinopathy, impaired wound healing, kidney disease, nerve damage, and cardiovascular disease. Alternative remedies, such as traditional medicine containing bioactive compounds, supplements, and aromatherapy, have been studied for their potential benefits in managing these complications. Traditional medicines like bitter melon, cinnamon, and fenugreek have been shown to have anti-diabetic effects due to their bioactive compounds. Similarly, supplements like vitamin D and Omega-3 fatty acids have been found to improve glycemic control in patients with diabetes. Aromatherapy, which involves the use of essential oils, has also been explored for its potential benefits in diabetes management. Homeopathy, which uses highly diluted substances to stimulate the body's natural healing abilities, has been used to treat diabetes-related symptoms like neuropathy and wounds. Personalized care is essential in natural diabetes management because each person's body and health needs are unique. A holistic approach that addresses the individual's physical, emotional, and spiritual well-being is essential. As research in this field continues to expand, a more comprehensive understanding of diabetes management will lead to improved outcomes for those living with this condition.

Keywords: Diabetes, glucose, alternative method, marketed formulation, vitamin D, kidney disease.

[1]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31(Suppl. 1): S55-60.
[http://dx.doi.org/10.2337/dc08-S055] [PMID: 18165338]
[2]
Nambam B, Winter W, Schatz D. Type 1 diabetes. Encycl Endocr Dis. 2018; pp. 110-5.
[http://dx.doi.org/10.1016/B978-0-12-801238-3.03820-4]
[3]
Pearson ER. Type 2 diabetes: A multifaceted disease. Diabetologia 2019; 62(7): 1107-12.
[http://dx.doi.org/10.1007/s00125-019-4909-y] [PMID: 31161345]
[4]
Ganesan K, Sultan S. Oral Hypoglycemic Medications. Treasure Island, (FL): StatPearls Publishing 2019.
[5]
Eren-Oruklu M, Cinar A, Quinn L, Smith D. Adaptive control strategy for regulation of blood glucose levels in patients with type 1 diabetes. J Process Contr 2009; 19(8): 1333-46.
[http://dx.doi.org/10.1016/j.jprocont.2009.04.004]
[6]
Eren-Oruklu M. Self-monitoring of blood glucose: Practical aspects. J Diabetes Sci Technol 2010; 4(2): 435-9.
[7]
Nielsen JK, Christiansen JS. Self-monitoring of blood glucose - Epidemiological and practical aspects. Diabetes Technol Ther 2008; 10(s1): S-35-42.
[http://dx.doi.org/10.1089/dia.2008.0007]
[8]
Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 2002; 25(2): 324-9.
[http://dx.doi.org/10.2337/diacare.25.2.324] [PMID: 11815504]
[9]
Gonder-Frederick LA, Cox DJ, Ritterband LM. Diabetes and behavioral medicine: The second decade. J Consult Clin Psychol 2002; 70(3): 611-25.
[http://dx.doi.org/10.1037/0022-006X.70.3.611] [PMID: 12090372]
[10]
Roden DM, Wilke RA, Kroemer HK, Stein CM. Pharmacogenomics. Circulation 2011; 123(15): 1661-70.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.109.914820] [PMID: 21502584]
[11]
Ahmed S, Zhou Z, Zhou J, Chen SQ. Pharmacogenomics of drug metabolizing enzymes and transporters: Relevance to precision medicine. Genom Proteom Bioinform 2016; 14(5): 298-313.
[http://dx.doi.org/10.1016/j.gpb.2016.03.008] [PMID: 27729266]
[12]
Mousa S, Mousa SS, Mousa SA. Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine. Pharm Genomics Pers Med 2009; 2: 79-91.
[http://dx.doi.org/10.2147/PGPM.S5806] [PMID: 23226037]
[13]
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev 2020; 16(5): 442-9.
[http://dx.doi.org/10.2174/18756417MTAxgODQqy] [PMID: 31657690]
[14]
Szalast P, Szarpak L. Emergency medicine point of view on epidemiology of diabetes and diabetes-related complications. Med J 2020; 5(1): 41-8.
[http://dx.doi.org/10.5603/DEMJ.a2020.0003]
[15]
Deshpande A, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008; 88(11): 1254-64.
[16]
Rübsam A, Parikh S, Fort P. Role of inflammation in diabetic retinopathy. Int J Mol Sci 2018; 19(4): 942.
[http://dx.doi.org/10.3390/ijms19040942] [PMID: 29565290]
[17]
Fung THM, Patel B, Wilmot EG, Amoaku WMK. Diabetic retinopathy for the non-ophthalmologist. Clin Med 2022; 22(2): 112-6.
[http://dx.doi.org/10.7861/clinmed.2021-0792] [PMID: 35304370]
[18]
Lechner J, O’Leary OE, Stitt AW. The pathology associated with diabetic retinopathy. Vision Res 2017; 139: 7-14.
[http://dx.doi.org/10.1016/j.visres.2017.04.003] [PMID: 28412095]
[19]
Guerrero JG. Best and effective practices of wound care and healing among patients with diabetes mellitus. Clin J Nurs Care Pract 2018; 2: 025-31.
[http://dx.doi.org/10.29328/journal.cjncp.1001009]
[20]
Hamed S, Bennett CL, Demiot C, Ullmann Y, Teot L, Desmoulière A. Erythropoietin, a novel repurposed drug: An innovative treatment for wound healing in patients with diabetes mellitus. Wound Repair Regen 2014; 22(1): 23-33.
[http://dx.doi.org/10.1111/wrr.12135] [PMID: 24471742]
[21]
Lim A. Diabetic nephropathy – complications and treatment. Int J Nephrol Renovasc Dis 2014; 7: 361-81.
[http://dx.doi.org/10.2147/IJNRD.S40172] [PMID: 25342915]
[22]
Sulaiman MK. Diabetic nephropathy: Recent advances in pathophysiology and challenges in dietary management. Diabetol Metab Syndr 2019; 11(1): 7.
[http://dx.doi.org/10.1186/s13098-019-0403-4] [PMID: 30679960]
[23]
Jones M. Diabetic nephropathy: Symptoms, causes and treatment. 2021. Available From : https://mydr.com.au/diabetes/diabeticnephropathy/
[24]
Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 2013; 17(1): 20-33.
[http://dx.doi.org/10.1016/j.cmet.2012.11.012] [PMID: 23312281]
[25]
Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes 2015; 6(3): 432-44.
[http://dx.doi.org/10.4239/wjd.v6.i3.432] [PMID: 25897354]
[26]
Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig 2011; 2(1): 18-32.
[http://dx.doi.org/10.1111/j.2040-1124.2010.00070.x] [PMID: 24843457]
[27]
Augustin LSA, Kendall CWC, Jenkins DJA, et al. Glycemic index, glycemic load and glycemic response: An international scientific consensus summit from the international carbohydrate quality consortium (ICQC). Nutr Metab Cardiovasc Dis 2015; 25(9): 795-815.
[http://dx.doi.org/10.1016/j.numecd.2015.05.005] [PMID: 26160327]
[28]
Schwingshackl L, Missbach B, König J, Hoffmann G. Adherence to a mediterranean diet and risk of diabetes: A systematic review and meta-analysis. Public Health Nutr 2015; 18(7): 1292-9.
[http://dx.doi.org/10.1017/S1368980014001542] [PMID: 25145972]
[29]
Martínez-González MA, Estruch R, Corella D, Ros E, Salas-Salvadó J. Prevention of diabetes with mediterranean diets. Ann Intern Med 2014; 161(2): 157-8.
[http://dx.doi.org/10.7326/L14-5014-2] [PMID: 25023257]
[30]
Martín-Peláez S, Fito M, Castaner O. Mediterranean diet effects on type 2 diabetes prevention, disease progression, and related mechanisms. A review. Nutrients 2020; 12(8): 2236.
[http://dx.doi.org/10.3390/nu12082236] [PMID: 32726990]
[31]
Jannasch F, Kröger J, Schulze MB. Dietary patterns and Type 2 diabetes: A systematic literature review and meta- analysis of prospective studies. J Nutr 2017; 147(6): 1174-82.
[http://dx.doi.org/10.3945/jn.116.242552] [PMID: 28424256]
[32]
Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344(1): 3-10.
[http://dx.doi.org/10.1056/NEJM200101043440101] [PMID: 11136953]
[33]
Kifle ZD, Bayleyegn B, Yimer Tadesse T, Woldeyohanins AE. Prevalence and associated factors of herbal medicine use among adult diabetes mellitus patients at government hospital, Ethiopia: An institutional-based cross-sectional study. Metabolism Open 2021; 11: 100120.
[http://dx.doi.org/10.1016/j.metop.2021.100120] [PMID: 34485891]
[34]
Rai A, Eapen C, Prasanth VG. Interaction of herbs and glibenclamide: A review. ISRN Pharmacol 2012; 2012: 1-5.
[http://dx.doi.org/10.5402/2012/659478] [PMID: 22844612]
[35]
Aluefua OF, Chika A, Muhammad AA, Usman A. Interactions between herbs and antidiabetic drugs: A systematic review. Res J Pharmacol 2017; 11(5-6): 6-17.
[36]
Amaeze OU, Aderemi-Williams RI, Ayo-Vaughan MA, Ogundemuren DA, Ogunmola DS, Anyika EN. Herbal medicine use among type 2 diabetes mellitus patients in Nigeria: Understanding the magnitude and predictors of use. Int J Clin Pharm 2018; 40(3): 580-8.
[http://dx.doi.org/10.1007/s11096-018-0648-2] [PMID: 29721742]
[37]
Qian J, Scheer FAJL. Circadian system and glucose metabolism: Implications for physiology and disease. Trends Endocrinol Metab 2016; 27(5): 282-93.
[http://dx.doi.org/10.1016/j.tem.2016.03.005] [PMID: 27079518]
[38]
Neelakantan N, Narayanan M, de Souza RJ, van Dam RM. Effect of fenugreek (Trigonella foenum-graecu mL.) intake on glycemia: A meta-analysis of clinical trials. Nutr J 2014; 13(1): 7.
[http://dx.doi.org/10.1186/1475-2891-13-7] [PMID: 24438170]
[39]
Barchuk OZ, Zaliska OM, Lysiuk RM, Denys AI, Smalyuh OG, Nester MI. Experimental study of goat’s rue (Galega Officinalis L.) herb and its liquid extracts. Pharma Innov J 2017; 6: 393-7.
[40]
AL-Ishaq RK. Abotaleb M, Kubatka P, Kajo K, Büsselberg D. Flavonoids and their anti-diabetic effects: Cellular mechanisms and effects to improve blood sugar levels. Biomolecules 2019; 9(9): 430.
[http://dx.doi.org/10.3390/biom9090430] [PMID: 31480505]
[41]
Marušić M, Paić M, Knobloch M, Liberati Pršo AM. NAFLD, Insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol 2021; 2021: 1-9.
[http://dx.doi.org/10.1155/2021/6613827] [PMID: 33681089]
[42]
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev 2018; 98(4): 2133-223.
[http://dx.doi.org/10.1152/physrev.00063.2017] [PMID: 30067154]
[43]
Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106(2): 171-6.
[http://dx.doi.org/10.1172/JCI10583] [PMID: 10903330]
[44]
Zoungas S, Chalmers J, Neal B, et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 2014; 371(15): 1392-406.
[http://dx.doi.org/10.1056/NEJMoa1407963] [PMID: 25234206]
[45]
de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett 2008; 582(1): 97-105.
[http://dx.doi.org/10.1016/j.febslet.2007.11.057] [PMID: 18053812]
[46]
Tie F, Wang J, Liang Y, et al. Proanthocyanidins ameliorated deficits of lipid metabolism in type 2 diabetes mellitus via inhibiting adipogenesis and improving mitochondrial function. Int J Mol Sci 2020; 21(6): 2029.
[http://dx.doi.org/10.3390/ijms21062029] [PMID: 32188147]
[47]
Silvis N. Nutritional recommendations for individuals with diabetes mellitus. S Afr Med J 1992; 81(3): 162-6.
[PMID: 1734559]
[48]
Azadbakht L, Rouhani MH, Surkan PJ. Omega-3 fatty acids, insulin resistance and type 2 diabetes. J Res Med Sci 2011; 16(10): 1259-60.
[PMID: 22973318]
[49]
Eraky SM, Abdel-Rahman N, Eissa LA. Modulating effects of omega-3 fatty acids and pioglitazone combination on insulin resistance through toll-like receptor 4 in type 2 diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 2018; 136: 123-9.
[http://dx.doi.org/10.1016/j.plefa.2017.06.009] [PMID: 28716464]
[50]
Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr 2011; 65(9): 1005-15.
[http://dx.doi.org/10.1038/ejcn.2011.118] [PMID: 21731035]
[51]
Mazloom Z, Yousefinejad A, Dabbaghmanesh MH. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial. Iran J Med Sci 2013; 38(1): 38-43.
[PMID: 23645956]
[52]
Park JH, Sung HY, Song DK. Green tea and type 2 diabetes. Integr Med Res 2009; 3(1): 4-10.
[http://dx.doi.org/10.1016/j.imr.2013.12.002]
[53]
Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: A review. Biol Trace Elem Res 2010; 134(2): 119-29.
[http://dx.doi.org/10.1007/s12011-009-8465-z] [PMID: 19629403]
[54]
Baska A, Leis K. Gałązka P. Berberine in the treatment of diabetes mellitus: A review. Endocr Metab Immune Disord Drug Targets 2021; 21(8): 1379-86.
[http://dx.doi.org/10.2174/1568026620666201022144405] [PMID: 33092516]
[55]
Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysis. Evid Based Complement Alternat Med 2012; 2012: 1-12.
[http://dx.doi.org/10.1155/2012/591654] [PMID: 23118793]
[56]
Can Çı̇çek S, Gençer Şendur E. Use of aromatherapy in diabetes management. J Tradit Complement Med 2021; 2(2): 115-20.
[http://dx.doi.org/10.53811/ijtcmr.959642]
[57]
CTRI/2018/08/015319. Homeopathy in pre-diabetes. 2018. Available From : https://trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2018/08/015319
[58]
Kumar GVN, Chitra V, Gupta P, Biswas B, Arya R. Preclinical updates of the homoeopathic medicines used in diabetes mellitus: A narrative review. Indian J Res Homoeopathy 2021; 15(1): 31.
[http://dx.doi.org/10.4103/ijrh.ijrh_96_19]
[59]
Nahar K, Kaushik S. Homoeopathy for management of type 2 diabetes mellitus in a patient of major depressive disorder - A case report. Indian J Res Homoeopathy 2021; 15(1): 55.
[http://dx.doi.org/10.4103/ijrh.ijrh_12_19]
[60]
Raveendran AV, Deshpandae A, Joshi SR. Therapeutic role of yoga in type 2 diabetes. Endocrinol Metab 2018; 33(3): 307-17.
[http://dx.doi.org/10.3803/EnM.2018.33.3.307] [PMID: 30112866]
[61]
Thent ZC, Das S, Henry LJ. Role of exercise in the management of diabetes mellitus: The global scenario. PLoS One 2013; 8(11): e80436.
[http://dx.doi.org/10.1371/journal.pone.0080436] [PMID: 24236181]
[62]
Sahay BK, Sahay RK. Lifestyle modification in management of diabetes mellitus. J Indian Med Assoc 2002; 100(3): 178-80.
[PMID: 12408279]
[63]
Amanat S, Ghahri S, Dianatinasab A, Fararouei M, Dianatinasab M. Exercise and type 2 Diabetes. Adv Exp Med Biol 2020; 1228: 91-105.
[http://dx.doi.org/10.1007/978-981-15-1792-1_6] [PMID: 32342452]
[64]
Stanford KI, Goodyear LJ. Exercise and type 2 diabetes: Molecular mechanisms regulating glucose uptake in skeletal muscle. Adv Physiol Educ 2014; 38(4): 308-14.
[http://dx.doi.org/10.1152/advan.00080.2014] [PMID: 25434013]
[65]
Francois ME, Little JP. Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectr 2015; 28(1): 39-44.
[http://dx.doi.org/10.2337/diaspect.28.1.39] [PMID: 25717277]
[66]
Hamasaki H. Interval exercise therapy for type 2 diabetes. Curr Diabetes Rev 2018; 14(2): 129-37.
[67]
Glauber HS, Rishe N, Karnieli E. Introduction to personalized medicine in diabetes mellitus. Rambam Maimonides Med J 2014; 5(1): e0002.
[http://dx.doi.org/10.5041/RMMJ.10136] [PMID: 24498509]
[68]
Mohan V, Das AK, Mukherjee JJ, Seshadri K, Jha S, Kalra S. From individualized to personalized medicine in diabetes: An expert overview. J Assoc Physicians India 2019; 67(9): 78-82.
[PMID: 31561694]
[69]
Walters-Salas ET. The challenge of patient adherence. Bariatr Nurs Surg Patient Care 2012; 7(4): 186.
[http://dx.doi.org/10.1089/bar.2012.9960]
[70]
Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag 2005; 1(3): 189-99.
[71]
Kanter M, Aksu F, Takir M, Kostek O, Kanter B, Oymagil A. Effects of low intensity exercise against apoptosis and oxidative stress in streptozotocin-induced diabetic rat heart. Exp Clin Endocrinol Diabetes 2017; 125(9): 583-91.
[http://dx.doi.org/10.1055/s-0035-1569332] [PMID: 26824288]
[72]
Omodanisi E, Aboua Y, Oguntibeju O, Lamuela-Raventós RM. Assessment of the anti-hyperglycaemic, anti-inflammatory and antioxidant activities of the methanol extract of moringa oleifera in diabetes-induced nephrotoxic male wistar rats. Molecules 2017; 22(4): 439.
[http://dx.doi.org/10.3390/molecules22040439] [PMID: 28333074]
[73]
Ozcelik M. Erişir M, Guler O, Baykara M, Kirman E. The effect of curcumin on lipid peroxidation and selected antioxidants in irradiated rats. Acta Vet Brno 2018; 87(4): 379-85.
[http://dx.doi.org/10.2754/avb201887040379]
[74]
Wang AN, Carlos J, Fraser GM, McGuire JJ. Zucker Diabetic‐Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model. Exp Physiol 2022; 107(4): 265-82.
[http://dx.doi.org/10.1113/EP089947] [PMID: 35178802]
[75]
Ugwu OP-C, Alum EU, Ben Okon M, Aja PM, Obeagu EI, Onyeneke EC. Ethanol root extract and fractions of sphenocentrum jollyanum abrogate hyperglycemia and low body weight in streptozotocin-induced diabetic wistar albino rats. RPS Pharm Pharmacol Reports 2023; 2(2): rqad010.
[http://dx.doi.org/10.1093/rpsppr/rqad01]

Rights & Permissions Print Cite
Article Metrics
9
2
© 2024 Bentham Science Publishers | Privacy Policy